Group One Trading
ORKA

Group One Trading’s Oruka Therapeutics ORKA Stock Holding History

Group One Trading’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.6K Sell
400
-100
-20% -$3.48K ﹤0.01% 5977
2025
Q4 		$15.2K Sell
500
-7,200
-94% -$201K ﹤0.01% 6560
2025
Q3 		$148K Buy
+7,700
New +$114K ﹤0.01% 4972
2024
Q4 		– Sell
-6,000
Closed -$147K – 8086
2024
Q3 		$147K Buy
6,000
+5,550
+1,233% +$193K ﹤0.01% 3882
2024
Q2 		$20.7K Buy
+450
New +$17.9K ﹤0.01% 5203
2023
Q2 		– Sell
-1,917
Closed -$45.8K – 8302
2023
Q1 		$45.8K Buy
1,917
+1,584
+476% +$41.7K ﹤0.01% 4917
2022
Q4 		$9.44K Sell
333
-44,359
-99% -$1.14M ﹤0.01% 6051
2022
Q3 		$1.1M Sell
44,692
-358
-0.8% -$10.1K ﹤0.01% 2480
2022
Q2 		$1.35M Buy
45,050
+45,008
+107,162% +$1.27M ﹤0.01% 2447
2022
Q1 		$1K Sell
42
-50
-54% -$1.24K ﹤0.01% 7896
2021
Q4 		$2K Sell
92
-508
-85% -$15.3K ﹤0.01% 7921
2021
Q3 		$21K Buy
+600
New +$22.2K ﹤0.01% 7155

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Group One Trading's ORKA Position: Q1 2026 in Review

Group One Trading held its Oruka Therapeutics (ORKA) position steady in Q1 2026 at 200 shares worth $9.81K. The position accounts for ﹤0.01% of the portfolio, ranked #6387.

Group One Trading first reported a position in ORKA in Q1 2021 and has held it in 10 quarters since. The position peaked at $327K in Q2 2022. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Group One Trading held 200 shares of Oruka Therapeutics worth $9.81K as of Q1 2026.
  • Group One Trading left its Oruka Therapeutics share count unchanged in Q1 2026.
  • Oruka Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6387 holding.
  • Group One Trading first reported a position in Oruka Therapeutics in Q1 2021 and has held it in 10 quarters since.
  • Group One Trading's Oruka Therapeutics position peaked at $327K in Q2 2022.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.